Ledger.Open graph →
SEC Form D · filed September 5, 2018

Fulcrum Therapeutics, Inc

Offering
$80.0M
Sold
$80.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

David J. Blumberg · San Francisco, CAExec · DirectorTyler Cauble · NASHVILLE, TNDirectorJett Fein · Sacramento, CADirectorTaylor S. Barbosa · Morrisville, NCDirectorRamin Karimpour · Morrisville, NCDirectorDhiren Jhaveri · Rosemont, ILExecHalf Moon GP, LLC · Larchmont, NYDirectorJake Joraanstad · Fargo, NDDirectorRalf Mehnert-Meland · Fargo, NDDirectorFred Day · Houston, TXDirectorHelen Newell · Houston, TXDirectorPriscilla Hill · Missouri City, TXExec · DirectorRaymond N. Catone · Fort Lauderdale, FLExecAlan Shipnuck · OCEANSIDE, CADirectorJames Tananbaum · Fort Washington, PADirectorAmit Hasija · Cambridge, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗